Impact of prostate volume on the active surveillance in prostate cancer

被引:0
|
作者
Beaujouan, Florent [1 ]
Bertherat, Walter [2 ]
Hammoudi, Zakaria [1 ]
Chicaud, Marie [1 ]
Descazeaud, Aurelien [1 ]
机构
[1] Univ Hosp Ctr Dupuytren, Dept Urol Surg & Androl, 16 rue Petiniaud-Beaupeyrat, F-87000 Limoges, France
[2] Perigueux Hosp Ctr, Dept Urol Surg & Androl, Perigueux, France
关键词
Prostatic neoplasms; active surveillance; prostate-specific antigen; prostatic hyperplasia; prognostic factors; FOLLOW-UP; ANTIGEN KINETICS; GUIDELINES; MANAGEMENT; DIAGNOSIS; OUTCOMES; PREDICT; UPDATE; BIOPSY; COHORT;
D O I
10.1177/20514158241303972
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the influence of the prostate volume (PVo) in the management of patients in active surveillance (AS) for prostate cancer. Materials and methods: A retrospective analysis of clinical, biological, histological and radiological data collected between 2010 and 2021 was performed for patients included in an AS protocol in a university hospital. The impact of initial PVo on the subsequent risk of exiting AS was evaluated. Results: In total, 109 patients were included in this analysis with a mean follow-up period of 52.74 +/- 31 months, 50% were out of AS by the end of the follow-up period. The risk of exiting the AS protocol was significantly associated to the PVo: patients with smaller PVo had an increased risk of exiting AS (p = 0.025). The maximal percentage of core invasion was the only initial predictive parameter for exiting the AS protocol on multivariate analysis of the global cohort (p = 0.010) and in the sub-group of patients having PVo <= 45 mL (p = 0.013). In the group having a PVo > 45 mL, no single initial parameter was significantly associated to a risk of exiting AS. Conclusion: Patients having small-sized prostate seemed to be at higher risk of exiting AS during follow-up.
引用
收藏
页数:11
相关论文
共 50 条
  • [11] Active surveillance for low-risk prostate cancer
    Herlemann, Annika
    Stief, Christian G.
    UROLOGE, 2016, 55 (02): : 269 - 278
  • [12] Active surveillance for prostate cancer
    Shill, Daniela K.
    Roobol, Monique J.
    Ehdaie, Behfar
    Vickers, Andrew J.
    Carlsson, Sigrid, V
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (06) : 2809 - 2819
  • [13] Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study
    Macleod, Liam C.
    Ellis, William J.
    Newcomb, Lisa F.
    Zheng, Yingye
    Brooks, James D.
    Carroll, Peter R.
    Gleave, Martin E.
    Lance, Raymond S.
    Nelson, Peter S.
    Thompson, Ian M., Jr.
    Wagner, Andrew A.
    Wei, John T.
    Lin, Daniel W.
    JOURNAL OF UROLOGY, 2017, 197 (04) : 1026 - 1033
  • [14] Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
    Bul, Meelan
    Zhu, Xiaoye
    Valdagni, Riccardo
    Pickles, Tom
    Kakehi, Yoshiyuki
    Rannikko, Antti
    Bjartell, Anders
    van der Schoot, Deric K.
    Cornel, Erik B.
    Conti, Giario N.
    Boeve, Egbert R.
    Staerman, Frederic
    Vis-Maters, Jenneke J.
    Vergunst, Henk
    Jaspars, Joris J.
    Stroelin, Petra
    van Muilekom, Erik
    Schroder, Fritz H.
    Bangma, Chris H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2013, 63 (04) : 597 - 603
  • [15] Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan
    Mitsuzuka, Koji
    Koga, Hirofumi
    Sugimoto, Mikio
    Arai, Yoichi
    Ohyama, Chikara
    Kakehi, Yoshiyuki
    Naito, Seiji
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (08) : 754 - 759
  • [16] The Role of MRI in Active Surveillance for Prostate Cancer
    Fascelli, Michele
    George, Arvin K.
    Frye, Thomas
    Turkbey, Baris
    Choyke, Peter L.
    Pinto, Peter A.
    CURRENT UROLOGY REPORTS, 2015, 16 (06)
  • [17] Update and optimization of active surveillance in prostate cancer
    Rubio-Briones, J.
    Pastor Navarro, B.
    Esteban Escano, L. M.
    Borque Fernando, A.
    ACTAS UROLOGICAS ESPANOLAS, 2021, 45 (01): : 1 - 7
  • [18] Prostate Cancer and the Increasing Role of Active Surveillance
    Alonzo, David Gabriel
    Mure, Amanda Lynne
    Soloway, Mark S.
    POSTGRADUATE MEDICINE, 2013, 125 (05) : 109 - 116
  • [19] Active surveillance of low risk prostate cancer
    Lellig, K.
    Beyer, B.
    Graefen, M.
    Zaak, D.
    Stief, C.
    UROLOGE, 2014, 53 (07): : 1031 - 1039
  • [20] Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN)
    Kato, Takuma
    Matsumoto, Ryuji
    Yokomizo, Akira
    Tohi, Yoichiro
    Fukuhara, Hiroshi
    Fujii, Yoichi
    Mori, Keiichiro
    Sato, Takuma
    Inokuchi, Junichi
    Hashine, Katsuyoshi
    Sakamoto, Shinichi
    Kinoshita, Hidefumi
    Inoue, Koji
    Tanikawa, Toshiki
    Utsumi, Takanobu
    Goto, Takayuki
    Hara, Isao
    Okuno, Hiroshi
    Kakehi, Yoshiyuki
    Sugimoto, Mikio
    BJU INTERNATIONAL, 2024, 134 (04) : 652 - 658